disease interaction(s) of Covid-19 with Alzheimer's disease
Jump to navigation
Jump to search
Pathology
- transcription factors PPARG, ZFPM2, ZNF415, HLX, & ANHX may accelerate & increase morbidity of Alzheimer's disease in patients with psoriasis through a positive feedback loop of inflammation & metabolic dysfunction[1]
* ZNF384 is a potential therapeutic target for psoriasis & Alzheimer's disease by regulating PPARG, ZNF415, HLX,& ANHX[1]
More general terms
References
- ↑ 1.0 1.1 1.2 Liu S, Yuan X, Su H et al ZNF384: A Potential Therapeutic Target for Psoriasis and Alzheimer's Disease Through Inflammation and Metabolism. Front Immunol. 2022 May 20;13:892368 PMID: https://www.ncbi.nlm.nih.gov/pubmed/35669784 PMCID: PMC9163351 Free PMC article